Damora Therapeutics
DMRA
#5408
Rank
A$2.17 B
Marketcap
A$35.08
Share price
-4.44%
Change (1 day)
35.10%
Change (1 year)

EPS for Damora Therapeutics (DMRA)

EPS in 2026 (TTM): A-$5.61

According to Damora Therapeutics's latest financial reports the company's current EPS (TTM) is A-$5.70. In 2025 the company made an earnings per share (EPS) of A-$6.01 an increase over its 2024 EPS that were of A-$28.00.

EPS history for Damora Therapeutics from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$5.61-6.77%
2025A-$6.01-78.52%
2024A-$28.00-48.64%
2023A-$54.51-40.61%
2022A-$91.7818.54%
2021A-$77.43-73.1%
2020A-$287.81131.17%
2019A-$124.5024.59%
2018A-$99.93